Boston Private Bank & Trust’s Quest Diagnostics DGX Stock Holding History

Boston Private Bank & Trust’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$794K	Hold	10,335	–	–	0.04%	249
2014 Q4	$693K	Sell	10,335 -75	-0.7%	-$4.73K	0.03%	268
2014 Q3	$632K	Sell	10,410 -510	-5%	-$31.4K	0.03%	271
2014 Q2	$641K	Sell	10,920 -2,300	-17%	-$135K	0.03%	264
2014 Q1	$766K	Sell	13,220 -940	-7%	-$50.4K	0.04%	252
2013 Q4	$758K	Sell	14,160 -4,180	-23%	-$248K	0.04%	254
2013 Q3	$1.13M	Sell	18,340 -1,100	-6%	-$65.8K	0.06%	223
2013 Q2	$1.18M	Buy	+19,440	New	+$1.16M	0.07%	211

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Boston Private Bank & Trust's DGX Position: Q1 2015 in Review

Boston Private Bank & Trust held its Quest Diagnostics (DGX) position steady in Q1 2015 at 10,335 shares worth $794K. The position accounts for 0.04% of the portfolio, ranked #249.

Boston Private Bank & Trust first reported a position in DGX in Q2 2013 and has held it in 8 quarters since. The position peaked at $1.18M in Q2 2013. 553 funds tracked by Wall St. Rank hold DGX as of Q1 2015.

Boston Private Bank & Trust held 10,335 shares of Quest Diagnostics worth $794K as of Q1 2015.
Boston Private Bank & Trust left its Quest Diagnostics share count unchanged in Q1 2015.
Quest Diagnostics made up 0.04% of Boston Private Bank & Trust's portfolio in Q1 2015, its #249 holding.
Boston Private Bank & Trust first reported a position in Quest Diagnostics in Q2 2013 and has held it in 8 quarters since.
Boston Private Bank & Trust's Quest Diagnostics position peaked at $1.18M in Q2 2013.
553 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.